$LFCR

Lifecore Biomedical, Inc.

About Lifecore Biomedical, Inc.

Lifecore Biomedical, Inc., together with its subsidiaries, operates as an integrated contract development and manufacturing organization that serves customers in the United States, Belgium, the Netherlands, and internationally. It provides services in the development, manufacture, aseptic fill, and finish of formulations and highly viscous sterile injectable pharmaceutical drug or medical device products in syringes, vials, and cartridges in various modalities. The company also manufactures and sells pharmaceutical-grade hyaluronic acid in bulk form, as well as for use in formulated and filled syringes and vials for injectable products used in treating various medical conditions and procedures, including ophthalmic and orthopedic applications. In addition, it offers product development services, including analytical method development and validation, formulation development, sterile filtration, process scale-up, pilot studies, stability studies, process validation, and materials production for clinical studies. The company was formerly known as Landec Corporation and changed its name to Lifecore Biomedical, Inc. in November 2022. Lifecore Biomedical, Inc. was founded in 1965 and is headquartered in Chaska, Minnesota.

CEO
Mr. Paul Josephs
Employees
382
Headquarters
Chaska, MN
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Website
lifecore.com

Key stats

Market Cap
$168.82M
P/E Ratio
Avg Volume (3M)
176.94K
EPS
-$1.27
Day's Range
$4.45 – $4.58

Fundamentals as of Sep 01, 2026